Jagsonpal Pharmaceuticals Ltd

📈 Jagsonpal Pharma Approves Rs. 40 Crore Share Buyback at Rs. 250/Share

- Buyback approved for up to 16 lakh equity shares

- Price set at Rs. 250 per share, totaling Rs. 40 Crores

- Aims to enhance shareholder value and improve EPS

- Initial board approval on March 12, 2026

- Company has over 40 years in pharmaceuticals

- Focuses on Gynaecology, Orthopaedics, Dermatology, and Child-care segments